1
|
Biagini M, Garibaldi M, Aprea S, Pezzicoli A, Doro F, Becherelli M, Taddei AR, Tani C, Tavarini S, Mora M, Teti G, D'Oro U, Nuti S, Soriani M, Margarit I, Rappuoli R, Grandi G, Norais N. The Human Pathogen Streptococcus pyogenes Releases Lipoproteins as Lipoprotein-rich Membrane Vesicles. Mol Cell Proteomics 2015; 14:2138-49. [PMID: 26018414 DOI: 10.1074/mcp.m114.045880] [Citation(s) in RCA: 40] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2014] [Indexed: 01/24/2023] Open
Abstract
Bacterial lipoproteins are attractive vaccine candidates because they represent a major class of cell surface-exposed proteins in many bacteria and are considered as potential pathogen-associated molecular patterns sensed by Toll-like receptors with built-in adjuvanticity. Although Gram-negative lipoproteins have been extensively characterized, little is known about Gram-positive lipoproteins. We isolated from Streptococcus pyogenes a large amount of lipoproteins organized in vesicles. These vesicles were obtained by weakening the bacterial cell wall with a sublethal concentration of penicillin. Lipid and proteomic analysis of the vesicles revealed that they were enriched in phosphatidylglycerol and almost exclusively composed of lipoproteins. In association with lipoproteins, a few hypothetical proteins, penicillin-binding proteins, and several members of the ExPortal, a membrane microdomain responsible for the maturation of secreted proteins, were identified. The typical lipidic moiety was apparently not necessary for lipoprotein insertion in the vesicle bilayer because they were also recovered from the isogenic diacylglyceryl transferase deletion mutant. The vesicles were not able to activate specific Toll-like receptor 2, indicating that lipoproteins organized in these vesicular structures do not act as pathogen-associated molecular patterns. In light of these findings, we propose to name these new structures Lipoprotein-rich Membrane Vesicles.
Collapse
Affiliation(s)
- Massimiliano Biagini
- From the ‡Novartis Vaccines and Diagnostics (a GSK company), Via Fiorentiina 1, 53100 Siena, Itlay
| | - Manuela Garibaldi
- From the ‡Novartis Vaccines and Diagnostics (a GSK company), Via Fiorentiina 1, 53100 Siena, Itlay
| | - Susanna Aprea
- From the ‡Novartis Vaccines and Diagnostics (a GSK company), Via Fiorentiina 1, 53100 Siena, Itlay
| | - Alfredo Pezzicoli
- From the ‡Novartis Vaccines and Diagnostics (a GSK company), Via Fiorentiina 1, 53100 Siena, Itlay
| | - Francesco Doro
- From the ‡Novartis Vaccines and Diagnostics (a GSK company), Via Fiorentiina 1, 53100 Siena, Itlay
| | - Marco Becherelli
- From the ‡Novartis Vaccines and Diagnostics (a GSK company), Via Fiorentiina 1, 53100 Siena, Itlay
| | - Anna Rita Taddei
- §Centro Interdipartimentale di Microscopia Elettronica, Università della Tuscia, Viterbo, Italy
| | - Chiara Tani
- From the ‡Novartis Vaccines and Diagnostics (a GSK company), Via Fiorentiina 1, 53100 Siena, Itlay
| | - Simona Tavarini
- From the ‡Novartis Vaccines and Diagnostics (a GSK company), Via Fiorentiina 1, 53100 Siena, Itlay
| | - Marirosa Mora
- From the ‡Novartis Vaccines and Diagnostics (a GSK company), Via Fiorentiina 1, 53100 Siena, Itlay
| | - Giuseppe Teti
- ¶Dipartimento di Scienze Pediatriche, Ginecologiche, Microbiologiche e Biomediche, Università degli Studi di Messina, Messina, Italy
| | - Ugo D'Oro
- From the ‡Novartis Vaccines and Diagnostics (a GSK company), Via Fiorentiina 1, 53100 Siena, Itlay
| | - Sandra Nuti
- From the ‡Novartis Vaccines and Diagnostics (a GSK company), Via Fiorentiina 1, 53100 Siena, Itlay
| | - Marco Soriani
- From the ‡Novartis Vaccines and Diagnostics (a GSK company), Via Fiorentiina 1, 53100 Siena, Itlay
| | - Immaculada Margarit
- From the ‡Novartis Vaccines and Diagnostics (a GSK company), Via Fiorentiina 1, 53100 Siena, Itlay
| | - Rino Rappuoli
- From the ‡Novartis Vaccines and Diagnostics (a GSK company), Via Fiorentiina 1, 53100 Siena, Itlay
| | - Guido Grandi
- From the ‡Novartis Vaccines and Diagnostics (a GSK company), Via Fiorentiina 1, 53100 Siena, Itlay
| | - Nathalie Norais
- From the ‡Novartis Vaccines and Diagnostics (a GSK company), Via Fiorentiina 1, 53100 Siena, Itlay;
| |
Collapse
|
2
|
Becherelli M, Prachi P, Viciani E, Biagini M, Fiaschi L, Chiarot E, Nosari S, Brettoni C, Marchi S, Biancucci M, Fontana MR, Montagnani F, Bagnoli F, Barocchi MA, Manetti AGO. Protective activity of the CnaBE3 domain conserved among Staphylococcus aureus Sdr proteins. PLoS One 2013; 8:e74718. [PMID: 24069334 PMCID: PMC3775735 DOI: 10.1371/journal.pone.0074718] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2013] [Accepted: 08/02/2013] [Indexed: 12/01/2022] Open
Abstract
Staphylococcus aureus is an opportunistic pathogen, commensal of the human skin and nares, but also responsible for invasive nosocomial as well as community acquired infections. Staphylococcus aureus adheres to the host tissues by means of surface adhesins, such as SdrC, SdrD, and SdrE proteins. The Sdr family of proteins together with a functional A domain, contain respectively two, three or five repeated sequences called B motifs which comprise the CnaB domains. SdrD and SdrE proteins were reported to be protective in animal models against invasive diseases or lethal challenge with human clinical S. aureus isolates. In this study we identified a 126 amino acid sequence containing a CnaB domain, conserved among the three Sdr proteins. The three fragments defined here as CnaBC2, D5 and E3 domains even though belonging to phylogenetically distinct strains, displayed high sequence similarity. Based on the sequence conservation data, we selected the CnaBE3 domain for further analysis and characterization. Polyclonal antibodies raised against the recombinant CnaBE3 domain recognized SdrE, SdrC and SdrD proteins of different S. aureus lineages. Moreover, we demonstrated that the CnaBE3 domain was expressed in vivo during S. aureus infections, and that immunization of this domain alone significantly reduces the bacterial load in mice challenged with S. aureus. Furthermore, we show that the reduction of bacteria by CnaBE3 vaccination is due to functional antibodies. Finally, we demonstrated that the region of the SdrE protein containing the CnaBE3 domain was resistant to trypsin digestion, a characteristic often associated with the presence of an isopeptide bond.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | - Sara Marchi
- Novartis Vaccines and Diagnostics, Siena, Italy
| | | | | | | | | | | | | |
Collapse
|
3
|
Abstract
Biofilm growth represents one of the most challenging problems associated with Candida infections, largely due to the natural resistance of biofilm to the common antifungal drugs. As elevated expression of heat shock proteins (HSP) promotes Candida yeast-hyphae switch, which is an essential step in biofilm formation, we investigated the expression of hsp genes during Candida albicans biofilm development. By measuring mRNA levels using qRT-PCR, we found that all three hsp genes that we monitored are overexpressed in the initial stage of C. albicans biofilm formation. To corroborate this finding, we examined the effect of 17-DMAG, a specific Hsp90 inhibitor, on the formation of C. albicans biofilm. Our results indicate the requirement of HSP during the early phase of Candida biofilm development.
Collapse
Affiliation(s)
- Marco Becherelli
- Infectious Diseases, Novartis Institutes for Biomedical Research Inc., Cambridge, Mass., USA
| | | | | |
Collapse
|
4
|
Becherelli M, Manetti AGO, Buccato S, Viciani E, Ciucchi L, Mollica G, Grandi G, Margarit I. The ancillary protein 1 of Streptococcus pyogenes FCT-1 pili mediates cell adhesion and biofilm formation through heterophilic as well as homophilic interactions. Mol Microbiol 2012; 83:1035-47. [PMID: 22320452 PMCID: PMC3490378 DOI: 10.1111/j.1365-2958.2012.07987.x] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/02/2022]
Abstract
Gram-positive pili are known to play a role in bacterial adhesion to epithelial cells and in the formation of biofilm microbial communities. In the present study we undertook the functional characterization of the pilus ancillary protein 1 (AP1_M6) from Streptococcus pyogenes isolates expressing the FCT-1 pilus variant, known to be strong biofilm formers. Cell binding and biofilm formation assays using S. pyogenes in-frame deletion mutants, Lactococcus expressing heterologous FCT-1 pili and purified recombinant AP1_M6, indicated that this pilin is a strong cell adhesin that is also involved in bacterial biofilm formation. Moreover, we show that AP1_M6 establishes homophilic interactions that mediate inter-bacterial contact, possibly promoting bacterial colonization of target epithelial cells in the form of three-dimensional microcolonies. Finally, AP1_M6 knockout mutants were less virulent in mice, indicating that this protein is also implicated in GAS systemic infection.
Collapse
Affiliation(s)
- Marco Becherelli
- Novartis Vaccines and Diagnostics, Via Fiorentina 1, Siena, Italy
| | | | | | | | | | | | | | | |
Collapse
|
5
|
Manetti AGO, Köller T, Becherelli M, Buccato S, Kreikemeyer B, Podbielski A, Grandi G, Margarit I. Environmental acidification drives S. pyogenes pilus expression and microcolony formation on epithelial cells in a FCT-dependent manner. PLoS One 2010; 5:e13864. [PMID: 21079780 PMCID: PMC2974651 DOI: 10.1371/journal.pone.0013864] [Citation(s) in RCA: 43] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2010] [Accepted: 10/18/2010] [Indexed: 01/24/2023] Open
Abstract
Group A Streptococcus (GAS, Streptococcus pyogenes) is a Gram-positive human pathogen responsible for a diverse variety of diseases, including pharyngitis, skin infections, invasive necrotizing fasciitis and autoimmune sequelae. We have recently shown that GAS cell adhesion and biofilm formation is associated with the presence of pili on the surface of these bacteria. GAS pilus proteins are encoded in the FCT (Fibronectin- Collagen-T antigen) genomic region, of which nine different variants have been identified so far. In the present study we undertook a global analysis of GAS isolates representing the majority of FCT-variants to investigate the effect of environmental growth conditions on their capacity to form multicellular communities. For FCT-types 2, 3, 5 and 6 and a subset of FCT-4 strains, we observed that acidification resulting from fermentative sugar metabolism leads to an increased ability of the bacteria to form biofilm on abiotic surfaces and microcolonies on epithelial cells. The higher biofilm forming capacity at low environmental pH was directly associated with an enhanced expression of the genes encoding the pilus components and of their transcription regulators. The data indicate that environmental pH affects the expression of most pilus types and thereby the formation of multicellular cell-adhering communities that assist the initial steps of GAS infection.
Collapse
Affiliation(s)
| | - Thomas Köller
- Institute of Medical Microbiology, Virology and Hygiene, Rostock, Germany
| | | | | | - Bernd Kreikemeyer
- Institute of Medical Microbiology, Virology and Hygiene, Rostock, Germany
| | - Andreas Podbielski
- Institute of Medical Microbiology, Virology and Hygiene, Rostock, Germany
| | | | | |
Collapse
|